Sigma-Aldrich's Q2 Sales Climb 14.4 Percent | GenomeWeb
NEW YORK (GenomeWeb News) – Sigma-Aldrich reported after the close of the market on Tuesday that its second-quarter revenues rose 14.4 percent, or 7.1 percent excluding the impact of currency translation.
 
The St. Louis-based research products and chemicals company brought in revenues of $580.7 million for the three-month period ended June 30 compared to revenues of $507.5 million for the second quarter of 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.